Corporations lock up your genome, while VCs flee biotech

Two posts worth checking out at VentureBeat Life Sciences:

1. Whiz-bang gene technology will soon let you play around with your own genome — but companies like 23andMe and Navigenics may lock it up and repeatedly charge you for access to it. Read about the emerging world of “corporate genomics” here.

[aditude-amp id="flyingcarpet" targeting='{"env":"staging","page_type":"article","post_id":48904,"post_type":"story","post_chan":"none","tags":null,"ai":false,"category":"none","all_categories":"business,","session":"A"}']

2. Funding for biotech and medical-device startups seemed pretty stable in the third quarter, but a closer look revealed that VCs are dropping the sector like a hot potato.